PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Genes reveal which patients will benefit from scleroderma drug

Finding avoids needless exposure to potentially toxic treatment

2013-04-10
(Press-News.org) CHICAGO --- Systemic sclerosis, also known as scleroderma, is a rare autoimmune connective tissue disorder that's difficult to treat. However, thanks to new research at Northwestern University Feinberg School of Medicine and Dartmouth's Geisel School of Medicine, doctors may be able to treat some patients more effectively.

Characterized by thickening of the skin, scleroderma can also cause significant complications in the joints and internal organs—particularly the esophagus, lower gastrointestinal tract, lungs, heart and kidneys. There is no cure—and the one drug commonly used to treat the disease, mycophenolate mofetile (MMF) does not work for all patients. In the absence of a biomarker to inform therapeutic medical decisions, patients are exposed to ineffective and potentially toxic medications.

In the first study of its kind in scleroderma, Monique Hinchcliff, M.D., assistant professor of medicine at the Feinberg School, associate director of the Northwestern Scleroderma Program, and a physician at Northwestern Memorial Hospital, and Michael Whitfield, associate professor of genetics at the Geisel School of Medicine, together have shown that gene expression signatures can accurately identify patients who will positively respond to a particular therapy.

The paper was recently published electronically in the Journal of Investigative Dermatology.

"There is the potential for adverse reactions including death with scleroderma therapies, and delay in initiating appropriate therapy can be harmful," Hinchcliff said. "Selecting effective treatment for each patient is the major issue facing physicians treating scleroderma patients."

Whitfield's and Hinchcliff's findings revealed that patients whose conditions improve with MMF therapy all share a particular gene expression pattern in skin.

During the clinical trial, patients who improved during MMF therapy were classified in the inflammatory gene expression subset, while patients who did not improve were classified in the normal-like or fibroproliferative gene expression subsets. This fits the initial hypothesis since MMF impairs lymphocyte proliferation.

An MMF response gene expression signature was also identified—the signature was composed of genes whose expression changed significantly during MMF treatment in patients that improved, but was absent in patients that did not improve.

The results of these experiments suggest that analysis of gene expression in skin may allow targeted treatment in patients with scleroderma.

While this is a small pilot study, it represents an important step forward in approaching complex rare diseases, such as scleroderma, where existing therapies show little or no efficacy, notes John Varga, M.D., the John and Nancy Hughes Professor at the Feinberg School and a physician at Northwestern Memorial, who also participated in the study.

If validated in a larger patient cohort now underway, the results will have significant impact on the development of effective treatment strategies for patients with systemic sclerosis.

INFORMATION:

The research paper is titled, "Molecular Signatures in Skin Associated with Clinical Improvement During Mycophenolate Treatment in Systemic Sclerosis." It can be found at: http://www.nature.com/jid/journal/vaop/naam/abs/jid2013130a.html

This work was supported in part by grants K12 HD055884 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health, grants U01 AR055063 and R25CA134286 from the National Cancer Institute from the National Institutes of Health, grants P60 AR48098 and P50AR060780 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health and by the Arthritis Foundation, the Scleroderma Foundation and the Scleroderma Research Foundation.

END



ELSE PRESS RELEASES FROM THIS DATE:

Adaptable leaders may have best brains for the job, study finds

2013-04-10
WASHINGTON – Effective leaders' brains may be physically "wired" to lead, offering the promise of more precise identification and training, according to studies of U.S. Army officers published by the American Psychological Association. Researchers have linked adaptive leadership skills with brain functioning and psychological complexity measures among active leaders. Those leaders who were found to be more adaptable and complex in psychological studies appeared to have brains that function differently from those of less adaptable leaders, according to an article published ...

Alcohol use, anxiety predict Facebook use by college students, MU study finds

2013-04-10
COLUMBIA, Mo. ¬— With nearly one billion users worldwide, Facebook has become a daily activity for hundreds of millions of people. Because so many people engage with the website daily, researchers are interested in how emotionally involved Facebook users become with the social networking site and the precursors that lead to Facebook connections with other people. Russell Clayton, now a doctoral student at the University of Missouri School of Journalism, found that anxiety and alcohol use significantly predict emotional connectedness to Facebook. Clayton's master's thesis, ...

Clinging to crevices, E. coli thrive

2013-04-10
Cambridge, Mass. – April 10, 2013 – New research from Harvard University helps to explain how waterborne bacteria can colonize rough surfaces—even those that have been designed to resist water. A team of materials scientists and microbiologists studied the gut bacterium Escherichia coli, which has many flagella that stick out in all directions. The researchers found that these tails can act as biological grappling hooks, reaching far into nanoscale crevices and latching the bacteria in place. The scourge of the health care industry, bacteria like E. coli are adept at ...

Mayo Clinic: Cardiopoietic 'smart' stem cells show promise in heart failure patients

2013-04-10
ROCHESTER, Minn. -- Translating a Mayo Clinic stem-cell discovery, an international team has demonstrated that therapy with cardiopoietic (cardiogenically-instructed) or "smart" stem cells can improve heart health for people suffering from heart failure. This is the first application in patients of lineage-guided stem cells for targeted regeneration of a failing organ, paving the way to development of next generation regenerative medicine solutions. Results of the clinical trial appear online of the Journal of the American College of Cardiology. The multi-center, randomized ...

Researchers identify critical metabolic alterations in triple-negative breast cancer cells

2013-04-10
WASHINGTON, DC (April 9, 2013)—Researchers at Fox Chase Cancer Center have identified a host of small molecules critical to metabolism in cells of triple-negative breast cancer—one of the least understood groups of breast cancer. These molecules, called metabolites, include key players in energy regulation and lipid synthesis. They could help pave the way for helping researchers differentiate among different forms of the disease and ultimately point to new targets for treatment. Jeffrey Peterson, PhD, a cancer biologist at Fox Chase, led the new studies, which also included ...

New technology spots drugs' early impact on cancer

2013-04-10
WASHINGTON, DC (April 9, 2013)—A new preclinical technology enables researchers to quickly determine if a particular treatment is effective against gastrointestinal stromal tumors (GISTs), providing a boost to animal research and possibly patient care, according to new findings presented by Fox Chase Cancer Center at the AACR Annual Meeting 2013 on Tuesday, April 9. The advantage of the tool, explains study author Lori Rink, PhD, assistant research professor at Fox Chase, is that it tells researchers if a particular compound is killing tumor cells in mice as early as ...

Research suggests new approach for spinal muscular atrophy

2013-04-10
PROVIDENCE, R.I. [Brown University] — There is no specific drug to treat spinal muscular atrophy (SMA), a family of motor neuron diseases that in its most severe form is the leading genetic cause of infant death in the United States and affects one in 6,000 people overall. But a new multispecies study involving a drug that treats amyotrophic lateral sclerosis (ALS) has pinpointed a mechanism of SMA that drug developers might be able to exploit for a new therapy. The research, published in the Journal of Neuroscience, reports that the drug Riluzole advanced neural cell ...

Manipulating calcium accumulation in blood vessels may provide a new way to treat heart disease

2013-04-10
Hardening of the arteries, or atherosclerosis, is the primary cause of heart disease. It is caused by calcium accumulation in the blood vessels, which leads to arteries becoming narrow and stiff, obstructing blood flow and leading to heart complications. Although many risk factors for atherosclerosis have been identified, the cause is not known and there is currently no way to reverse it once it sets in. In a new study published 9th April in the open access journal PLOS Biology, researchers have characterized the cells responsible for driving this calcium build-up in vessel ...

Bean leaves can trap bedbugs, researchers find

2013-04-10
Irvine, Calif. – Inspired by a traditional Balkan bedbug remedy, researchers have documented how microscopic hairs on kidney bean leaves effectively stab and trap the biting insects, according to findings published online today in the Journal of the Royal Society Interface. Scientists at UC Irvine and the University of Kentucky are now developing materials that mimic the geometry of the leaves. Bedbugs have made a dramatic comeback in the U.S. in recent years, infesting everything from homes and hotels to schools, movie theaters and hospitals. Although not known to transmit ...

New gene associated with almost doubled Alzheimer's risk in African-Americans

2013-04-10
NEW YORK – African-Americans with a variant of the ABCA7 gene have almost double the risk of developing late-onset Alzheimer's disease compared with African-Americans who lack the variant. The largest genome-wide search for Alzheimer's genes in the African-American community, the study was undertaken by the Alzheimer's Disease Genetics Consortium and led by neurologists from Columbia University Medical Center. It will be published in the April 10 issue of the Journal of the American Medical Association. The study was primarily funded by the National Institutes of Health ...

LAST 30 PRESS RELEASES:

Wetland plant-fungus combo cleans up ‘forever chemicals’ in a pilot study

Traditional Chinese medicine combined with peginterferon α-2b in chronic hepatitis B

APS and SPR honor Dr. Wendy K. Chung with the 2026 Mary Ellen Avery Neonatal Research Award

The Gabriella Miller Kids First Data Resource Center (Kids First DRC) has launched the Variant Workbench

Yeast survives Martian conditions

Calcium could be key to solving stability issues in sodium-ion batteries

Can smoother surfaces prevent hydrogen embrittlement?

Heart rate changes predict depression treatment success with magnetic brain stimulation

Genetics pioneer transforms global depression research through multi-omics discoveries

MDMA psychiatric applications synthesized: Comprehensive review examines PTSD treatment and emerging therapeutic indications

Psychedelics offer new therapeutic framework for stress-related psychiatric disorders

Brain cell discoveries reshape understanding of psychiatric disorders

Mom’s voice boosts language-center development in preemies’ brains, study finds

Development of silicon ultrasound patch achieves both eco-friendliness and performance enhancement

Measles immunity 90% in BC’s Lower Mainland

Women’s brain regions may lose ability to synchronize after sexual assault

Quitting smoking, even late in life, linked to slower cognitive decline

Critical raw materials are a vital new currency; Europe’s e-waste is the vault

Anesthesiologist-led care helps hip-fracture patients get to surgery faster, with fewer complications

Two-dose recombinant shingles vaccine is effective even accounting for prior receipt of live shingles vaccine

Excessive daytime sleepiness may raise risk of cognitive problems after surgery

Flipping the switch on sperm motility offers new hope for male infertility

Twisting sound: Scientists discover a new way to control mechanical vibrations in metamaterial

Drip by drip: The hidden blueprint for stalagmite growth

mRNA therapy restores sperm production and fertility in mice

New way to weaken cancer cells could supercharge prostate cancer treatment

How sound—but not touch—shapes rhythm in the brain

Exploring the therapeutic potential of hypothermia

Research alert: Bioengineering breathes new life into failed cancer treatment

AI, health, and health care today and tomorrow – the JAMA Summit Report on artificial intelligence

[Press-News.org] Genes reveal which patients will benefit from scleroderma drug
Finding avoids needless exposure to potentially toxic treatment